Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer Pranav MurthyMazen S. ZenatiBrian A. Boone Pancreatic Tumors 02 December 2019 Pages: 898 - 906
ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma Pranav MurthyBrian A. Boone ASO Author Reflections 10 December 2019 Pages: 907 - 908
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection Ryan J. EllisJessie W. HoAnthony D. Yang Pancreatic Tumors 05 November 2019 Pages: 909 - 918
Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans Hayden SnowEmma DaviesAndrew J. Hayes Sarcoma 29 October 2019 Pages: 919 - 923
High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer Kei HagiwaraNorifumi HarimotoKen Shirabe Translational Research and Biomarkers 28 August 2019 Pages: 924 - 930
ASO Author Reflections: Clinical Significance of Large Tenascin C Splice Variants and Annexin A2 for Pancreatic Cancer Kei HagiwaraNorifumi HarimotoKen Shirabe ASO Author Reflections 22 November 2019 Pages: 931 - 932
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors Nobuhiro NakazawaTakehiko YokoboriKen Shirabe Translational Research and Biomarkers 30 September 2019 Pages: 933 - 942
ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer Nobuhiro NakazawaTakehiko YokoboriKen Shirabe ASO Author Reflections 06 November 2019 Pages: 943 - 944
Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component Naoto KishiMasaoki ItoMorihito Okada Translational Research and Biomarkers 15 November 2019 Pages: 945 - 955
Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious Xu-Heng ChiangMong-Wei LinJin-Shing Chen Thoracic Oncology 17 December 2019 Pages: 956 - 957
Sublobar Resection for Clinical IA Non-Small Cell Lung Cancer: One Size Fits All? Han-Yu Deng Thoracic Oncology 19 December 2019 Pages: 958 - 959
Is There a Role for Surgery in Treating Localized Esophageal Neuroendocrine Tumor? Han-Yu Deng Thoracic Oncology 11 December 2019 Pages: 960 - 961
Reply to the Editor: “Is There a Role of Surgery in Treating Localized Esophageal Neuroendocrine Tumor?” Suna ErdemRene WarschkowMathias Worni Endocrine Tumors 11 December 2019 Pages: 962 - 962